Vincera Pharma Inc
(VINC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,157 | -35,207 | -26,200 | -14,650 | -62,984 |
| Depreciation Amortization | 285 | 54 | 403 | -183 | 647 |
| Accounts payable and accrued liabilities | -1,568 | -1,003 | -532 | 2,108 | 1,046 |
| Other Working Capital | -4,191 | -375 | -2,059 | 375 | -1,020 |
| Other Operating Activity | 5,178 | 4,097 | 2,599 | -742 | 2,707 |
| Operating Cash Flow | $-40,453 | $-32,434 | $-25,789 | $-13,092 | $-59,604 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -11,821 | -11,821 | -10,588 | -4,192 | -42,978 |
| Sale Of Investment | 53,321 | 47,571 | 31,277 | 10,077 | 2,400 |
| Investing Cash Flow | $41,500 | $35,750 | $20,689 | $5,885 | $-40,578 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 114 | 96 | 96 | 3 | 280 |
| Financing Cash Flow | $114 | $96 | $96 | $3 | $280 |
| Exchange Rate Effect | -40 | 3 | 20 | 30 | 71 |
| Beginning Cash Position | 11,733 | 11,733 | 11,733 | 11,733 | 111,564 |
| End Cash Position | 12,854 | 15,148 | 6,749 | 4,559 | 11,733 |
| Net Cash Flow | $1,121 | $3,415 | $-4,984 | $-7,174 | $-99,831 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,453 | -32,434 | -25,789 | -13,092 | -59,604 |
| Free Cash Flow | -40,453 | -32,434 | -25,789 | -13,092 | -59,604 |